Tissue inhibitor of metalloproteinases-1 (TIMP-1), a natural inhibitor of matrix metalloproteinases (MMPs), is known to inhibit invasion and metastasis of tumor cells. In the present study we examined anti-tumor promoter activity of TIMP-1 and its effect on in vitro cell transformation using BALB/3T3 cells in low serum culture medium. 
Introduction
It has been recognized that there are at least two distinct steps, an initiation step and a promotion step, in the processes of in vitro cell transformation and in vivo carcinogenesis. During the past few decades much knowledge has been accumulated about genes and intracellular events involved in oncogenic transformation of mammalian cells, but the exact molecular mechanism of tumor progression is not yet clearly understood. It has been reported that some serine proteinase inhibitors, such as soybean-derived Bowman-Birk protease inhibitor and leupeptin, act as antitumor promoters and suppress in vitro cell transformation and in vivo carcinogenesis induced by a variety of carcinogens (1, 2) . This means that some serine proteinases are involved in the process of carcinogenesis.
The representative tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA*) is known to have pleiotropic effects on various types of cells: it induces expression of a number of genes and modulates cell proliferation by activating protein kinase C-dependent and/or -independent signal pathways (3, 4) . Some matrix metalloproteinases (MMPs), such as gelatinase B (MMP-9) (5), stromelysin 1 (MMP-3) (6), stromelysin 2 (MMP-10), interstitial collagenase (MMP-1) and matrilysin (MMP-7), have a TPA-responsive element in their promoter regions, which binds activator protein-1 and promotes gene expression, and hence their transcription is potently stimulated by TPA (7) (8) (9) .
MMPs are overexpressed in many kinds of cancer cell lines (8, 9) and tumor tissues (8, 10, 11) . Some MMPs, such as stromlysin-1 (12, 13) and gelatinase B (14) , are induced in the process of oncogenic transformation. These MMPs are believed to play an essential role in matrix degradation during the processes of invasion by and metastasis of tumor cells (10, 11) . The activity of MMPs is regulated by at least four kinds of endogenous tissue inhibitors of metalloproteinases (TIMPs) (10, 11) . Among the TIMP family, TIMP-1, a glycoprotein with a molecular mass of~28 kDa, was the first identified member (15, 16) and its gene expression is induced by TPA (7) (8) (9) . TIMP-1 is expressed in many types of cells, including tumor cells (7) (8) (9) , and is able to inhibit tumor cell invasion in vitro (8, 17, 18) and experimental metastasis in vivo (18, 19) . TIMP-1 exists in various body fluids, including blood (20) . It has been reported that expression of antisense RNA against TIMP-1 mRNA converts non-tumorigenic Swiss 3T3 cells into tumorigenic cells with metastatic potential (21) . All of these facts led us to speculate that MMPs might participate in tumor promotion and TIMP-1 might have anti-tumor promoting activity.
To assay the anti-tumor promoting activity of TIMP-1, we chose the dye transfer method and the in vitro twostage transformation assay using BALB/3T3 cells. The dye transfer method is one of the methods for measuring gap junctional intercellular communication (GJIC). Under the usual culture conditions fluorescent dye injected into cells can be transferred to neighboring cells through GJIC. Many tumor promoters inhibit GJIC and therefore prevent dye transfer (22) (23) (24) , while anti-tumor promoters prevent inhibition of dye transfer by tumor promoters (22, (25) (26) (27) . The in vitro two-stage transformation assay has been recognized to be directly relevant to carcinogenesis and is regarded as one of the most useful methods for screening possible carcinogens (28, 29) . In the present study with the two assay systems, we demonstrate that TIMP-1 has anti-tumor promoting and anti-carcinogenic activities on BALB/3T3 cells.
Materials and methods

Reagents
Chemicals were obtained from the following sources: N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) from Aldrich Chemical Co. (Milwaukee, WI); TPA from Wako Pure Chemical Industries (Tokyo, Japan); dimethylsulfoxide (DMSO) and Lucifer Yellow CH from Sigma Chemical Co. (St Louis, MO). TIMP-1 was purified from serum-free culture medium conditioned by human bladder carcinoma cell line EJ-1 as reported previously (30) . Purified TIMP-2 was a generous gift from Dr H.Takaku (Bioscience Research Laboratories, Japan Energy, Saitama, Japan). A synthetic hydroxamic acid inhibitor for MMPs, KB8301, was a generous gift from Dr K.Yoshino (Kanebo Institute for Cancer Research, Osaka, Japan).
Cells and cell culture BALB/3T3 A31-1-1 clonal cells were grown in minimal essential medium (MEM; Nissui Pharmaceutial Co., Tokyo, Japan) supplemented with 10% fetal calf serum (FCS). Other media used in the dye transfer and in vitro transformation experiments were obtained from the following sources: T medium (modified DME/F-12 medium) and ITES (a mixture of 200 µg/ ml bovine pancreas insulin, 200 µg/ml human transferrin, 12.2 µg/ml ethanolamine and 0.034 µg/ml sodium selenite) from Wako Pure Chemical Industries; DME/F-12 from Gibco BRL (Grand Island, NY). Human bladder carcinoma cell line EJ-1, which was used for purification of TIMP-1, was grown in autoclavable RPMI 1640 medium (Nissui Pharmaceutial Co.) supplemented with 10% FCS. The two cell lines were provided by the Japanese Cancer Research Resources Bank. They were cultured in a humidified incubator under 5% CO 2 and 95% air.
Dye transfer assay
The dye transfer assay was carried out according to the method of Takahashi et al. (27) . BALB/3T3 A31-1-1 cells were seeded at 4ϫ10 3 cells/35 mm dish in 2 ml T medium supplemented with 1% ITES and 2% FCS. Medium changes were performed on days 3, 5 and 8 after plating. In a typical assay TPA and TIMP-1 were added to final concentrations of 100 and 1000 ng/ml, respectively, to cultures on days 5 and 8. Microinjection of 10% Lucifer Yellow CH in 0.33 M lithium chloride into cells was carried out under an inverted phase contrast microscope (TMD 10; Nikon Co., Tokyo, Japan) using a glass capillary needle prepared with an automatic magnetic puller (Narishige Co., Tokyo, Japan). The dye was injected continuously for~0.5 s by hand pressure. After 10-20 min at room temperature the medium was changed to Hanks' balanced salt solution without phenol red and the number of dyed cells around the injected cell was counted under a fluorescent microscope with a BA filter. Data were statistically analyzed by the Mann-Whitney U test.
Cell transformation assay
Cell transformation by MNNG was carried out according to the method of Tsuchiya and Umeda (31) with some modifications. Briefly, BALB/3T3 A31-1-1 cells were seeded at 1.5ϫ10 5 cells/60 mm dish in 5 ml MEM supplemented with 10% FCS and incubated for 2 days. During incubation the cells reached subconfluence. The cells were then treated with 0.5 µg/ ml MNNG for 4 h. The treated cells were trypsinized and seeded into culture dishes to examine viability, and malignant transformation. For this replating DME/F-12 medium supplemented with 1% ITES and 2.5% FCS was used. For assay of cell viability colony-forming efficiency was determined by plating 100-200 MNNG-treated cells into 60 mm dishes. After 7 days cultivation the cultures were fixed with methanol and stained with Giemsa solution and colonies were counted. For the transformation assay, MNNG-treated cells were replated into 60 mm plastic dishes (10 dishes for each treatment) at a cell density of 4-6ϫ10 3 viable cells/60 mm dish, where the number of viable cells was estimated on the basis of preliminary viability assay. The dishes were incubated for 3 weeks with two medium changes per week. TPA was added at 100 ng/ml 1 week after replating and the cells were kept in the presence of the promoter for 11 days. MMP inhibitors were added 4 days after replating and the cells were incubated in the presence of the inhibitors for 17 days. Three weeks (21 days) after replating the cells were fixed with methanol and stained with Giemsa solution. Transformation foci of types II and III with diameters Ͼ2 mm were scored according to the criteria described elsewhere (29, 31) . These foci had the following properties: dense, multilayered and basophilic. We have previously reported that these transformed cells are malignant (28, 29) .
In order to obtain constant results, we used the cells in a very confined window of passage generations, even though older cell cultures could be used for the experiments. Frozen stock ampoules of the cells were prepared between passages 11 and 13 after supply of the cells. One ampoule was 2094 thawed and used for each experiment. Data were statistically analyzed by the Mann-Whitney U test.
Zymographic analysis of metalloproteinases secreted by BALB/3T3 cells
BALB/3T3 cells were grown to confluence in 150 mm plastic dishes in growth medium. The cultures were then rinsed three times with Ca 2ϩ / Mg 2ϩ -free Hanks' balanced salt solution and then 20 ml serum-free MEM medium containing 100 ng/ml TPA or 0.1% (v/v) DMSO as the vehicle for TPA were added. Two days later the serum-free conditioned medium was harvested and clarified by sequential centrifugation at 800 g for 5 min and at 10 000 g for 15 min. Then this conditioned medium was concentrated 60-fold by ammonium sulfate precipitation. Zymographic analyses of the concentrated conditioned media were carried out as described previously (32) . Briefly, sample proteins were run on 10% polyacrylamide slab gels (90 mm longϫ90 mm wideϫ0.75 mm thick) containing 1 mg/ml gelatin or casein under non-reducing conditions. Metalloproteinases separated on the gels were renatured in 50 mM TrisHCl buffer, pH 7.5, containing 2.5% (v/v) Triton X-100 and 0.1 M NaCl. The renatured gels were incubated in 20 mM Tris-HCl buffer, pH 7.5, containing 10 mM CaCl 2 and 5 mM diisopropyl fluorophosphate as a serine proteinase inhibitor at 37°C for 18 h. The gels were stained with Coomassie Brilliant Blue R-250.
Results
Dye transfer assay
To assay anti-tumor promoter activity of TIMP-1, its effect on GJIC of BALB/3T3 cells was examined by the dye transfer method. When cells were seeded at 4ϫ10 3 cells/35 mm dish in 2 ml T medium ϩ 1% ITES ϩ 2% FCS medium, the number of cells increased up to day 8 and then decreased a little, reaching a confluent steady-state. TPA was added to the cultures on days 5 and 8 at the times of medium change and GJIC of the cells was assayed daily from days 5 to 10 ( Figure 1 ). When dye transfer was examined 4 h after the first TPA addition on day 5, GJIC was remarkably inhibited compared with the non-treated cultures. This inhibition of GJIC recovered to the control level by day 7. When TPA was added again to this culture on day 8, the level of GJIC decreased as before. Unlike the first inhibition of GJIC, however, the second inhibition of GJIC was not transient and continued until day 10.
When TIMP-1 was added to the medium at a final concentration of 1000 ng/ml together with 100 ng/ml TPA, The dye transfer assay to measure GJIC was carried out daily between days 5 and 10. The results are presented as a percentage of the control (0.5% DMSO as solvent). d, TPA (100 ng/ml) alone; s, TPA (100 ng/ml) plus TIMP-1 (1000 ng/ml). Each point represents mean Ϯ SD for 20 injections in total in duplicate dishes. In the control (100%) the number of dye coupled cells was 12.5 on average. a, significant difference between two groups as determined by Mann-Whitney U test, P Ͻ 0.0001. Other experimental conditions are described in Materials and methods. the first transient inhibition of GJIC and its subsequent recovery were observed as in the case of TPA treatment alone ( Figure 1) . The second addition of both TPA and TIMP-1 to the culture on day 8 brought about a similar rapid inhibition of GJIC to that after the first addition. In contrast to TPA treatment alone, however, the level of GJIC in TIMP-1-treated cells recovered to the control level on the next day (day 9). Thus TIMP-1 effectively inhibited the continuous suppression of GJIC level induced by the second TPA treatment. Figure 2 shows representative photographs of BALB/3T3 cells microinjected with Lucifer Yellow CH on day 10 of culture. When the fluorescent dye was injected into control cells, the dye spread to neighboring cells through GJIC (Figure 2A and B) . In the case of cells treated with 100 2095 ng/ml TPA, alone the dye did not spread to neighboring cells ( Figure 2C and D) . When TIMP-1 was added simultaneously with TPA, spreading of the dye was observed as in the control culture, demonstrating recovery of GJIC ( Figure 2E and F) .
To confirm the above results, the dose dependence of the effect of TIMP-1 was also examined. As shown in Figure  3 , the recovery of GJIC level after the second TPA treatment was dependent on TIMP-1 concentration from 1 to 1000 ng/ml. GJIC of the cells treated with 100 ng/ml TIMP-1 reached the same level as that of control cells which received neither TPA nor TIMP-1 treatment.
Transformation assay
We next examined the effect of TIMP-1 on in vitro twostage cell transformation. In the assay BALB/3T3 cells were treated with 0.5 µg/ml MNNG as initiator and then incubated for 3 weeks in the presence of 100 ng/ml TPA as promoter and various concentrations of TIMP-1. The results are summarized in Table I , and transformed foci formed in typical dishes are shown in Figure 4 . Single treatment with either MNNG or TPA induced 0.2 or 0.4 transformation foci/dish on average respectively, whereas treatment with MNNG followed by TPA induced 2.7 transformation foci/ dish (transformation control). When TIMP-1 was added to this culture, the number of transformation foci was decreased. At 10 ng/ml TIMP-1 the number of transformation foci was decreased to 1.2/dish (56% inhibition) from 2.7/dish in the control dishes. An increase in the TIMP-1 concentration to Ͼ10 ng/ml did not lead to a further significant decrease in transformation foci (63% inhibition at 100 ng/ml). Inhibition of cell transformation by TIMP-1 was statistically significant To determine whether inhibition of cell transformation by TIMP-1 depends on its MMP-inhibitory activity, we next examined the effect of another natural inhibitor, TIMP-2, and a synthetic MMP inhibitor, KB8301, on in vitro twostage transformation. As shown in Table II , TIMP-2 inhibited formation of transformation foci by~60% at as low as 1 ng/ml. Similarly, when the hydroxamic acid MMP inhibitor KB8301, which inhibited the activities of interstitial collagenase, stromelysin and gelatinase B by 50% at 0.3-0.6 nM, was added to the culture at concentrations of 1 and 10 nM, the number of transformation foci was decreased to~40% of the control (Table II) . These results indicate that MMP activities were involved in the in vitro cell transformation.
Since TIMP-1 and TIMP-2 have been reported to stimulate or inhibit growth of various types of cells (33, 34) , it is possible that they affect in vitro cell transformation by modulating cell growth. Therefore, we further examined the effect of TIMP-1 on growth of BALB/3T3 clone A31-1-1 and its trasformed clone under the same conditions as used for in vitro cell transformation. TIMP-1 neither stimulated nor inhibited growth of either type of cell in culture medium containing 1% ITES and 2.5% FCS (data not shown). This indicated that inhibition of cell transformation by TIMP-1 does not depend on its growth modulating effect.
Induction of MMPs by TPA in BALB/3T3 cells
The results described above strongly suggest that the antitumor promoter activity of TIMP-1 depends on its inhibitory activity on MMPs. To reveal MMPs involved in in vitro cell transformation, the conditioned medium of BALB/3T3 cells incubated with and without TPA were analyzed for secreted MMPs by zymography on gelatin-and caseincontaining gels ( Figure 5 ). In gelatin zymography the conditioned medium of the control cells showed gelatinolytic activities at apparent molecular weights (M r ) of 64 000 and 90 000. TPA treatment significantly increased the activity at M r 90 000 but not that at M r 64 000. In casein zymography the control cells showed no caseinolytic activity, whereas the TPA-treated cells showed weak bands at M r electrophoretic mobilities with authentic human enzymes and from their susceptibility to metalloproteinase inhibitors, the activities at M r 90 000, 64 000 and 52 000 were judged to correspond to the proforms of gelatinase B, gelatinase A and stromelysin, respectively. These results indicate that TPA induces at least gelatinase B and stromelysin in BALB/ 3T3 cells.
Discussion
Using two in vitro assay systems, we have shown that TIMP-1 has anti-tumor promoter activity on BALB/3T3 cells and suppresses their malignant transformation. TIMP-1 is widely distributed in tissues and body fluids (20) . 
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Normal human serum and fetal calf serum contain~180 and 210 ng/ml TIMP-1 on average, respectively (20, 33) . TIMP-2 exists in normal human serum at a concentration of~60 ng/ml (35) . Previously, Tsuchiya and Umeda reported that culture medium supplemented with 1% ITES and 2% FCS supported efficient transformation of BALB/3T3 cells by MNNG and TPA (31) . In the present study, low serum media, which contained TIMP-1 at a final concentration of 4-5 ng/ml, were successfully used to show the anti-tumor promoter activity of TIMP-1 at 1-100 ng/ml. In the dye transfer method, TIMP-1 could not block transient inhibition of GJIC induced by TPA in the growing phase, but it quickly restored the GJIC level reduced by a second addition of TPA to the normal level in cultures at confluent steady-state. Enomoto et al. (36) have suggested that continuously blocked GJIC in the confluent phase is more important than transient inhibition in the growth phase for promotion of in vitro two-stage cell transformation. Therefore, prevention of continuously inhibited GJIC in the confluent phase by TIMP-1 may be important in malignant transformation of cells. We have observed similar anti-tumor promoting effects of leupeptin, soybean trypsin inhibitor, ascorbic acid and retinoic acid (data not shown), all of which have been reported as anti-tumor promoters in in vivo or in vitro experiments (1, 2, 37) .
In the in vitro two-stage transformation assay, TIMP-1 inhibited malignant transformation of BALB/3T3 cells bỹ 60%. This confirmed the anti-tumor promoter activity of TIMP-1. TIMP-1 and TIMP-2 are known to not only inhibit MMP activities but also modulate various cellular functions, such as cellular growth (33, 38) , differentiation (16), embryonic development (39) , angiogenesis (40) and tumor invasion/ metastasis (8, (17) (18) (19) . Some of the effects are considered to be independent of the anti-MMP activity. For example, TIMP-1 stimulates growth of various types of cells in vitro (33) . This growth stimulating activity of TIMP-1 is believed to result from its direct action on a cell surface receptor (34) . For the following reasons, however, we consider that the anti-tumor promoting activity of TIMP-1 depends on its anti-MMP activity. First, in the present study not only TIMP-1 but also TIMP-2 and a synthetic MMP inhibitor significantly suppressed in vitro cell transformation and TIMP-1 did not affect growth of BALB/3T3 cells. Second, the tumor promoter TPA is known to potently induce expression of some MMP genes (5-9). Indeed, we found in this study that TPA induced gelatinase B and stromelysin in BALB/3T3 cells. The inflammatory cytokine tumor necrosis factor-α (TNF-α), which has been regarded as an endogenous tumor promoter (41) , also induces MMPs (7, 8, 42) . In this study we confirmed that TNF-α induced the same MMPs in BALB/3T3 cells as TPA and it could substitute for TPA in the in vitro two-stage transformation assay (data not shown). On the other hand, the anti-promoter retinoic acid is known to suppress gene expression of these MMPs (43) . Third, stromelysin and gelatinase B are known to be induced by oncogenic transformation (12) (13) (14) . Fourth, serine proteinase inhibitors are known to have anti-tumor promoter activity (1, 2) . Many MMPs, including gelatinase B, stromelysin and collagenase, are secreted in latent forms and the latent pro-MMPs are effectively activated by serine proteinases such as trypsin and plasmin (13, 32, 44) . Therefore, a proteinase cascade of serine proteinases and MMPs may be involved in cell transformation and in vivo carcinogenesis. It also should be noted that TPA and TNF-α induce not only MMPs but also TIMP-1. This apparently contradicts the anti-tumor promoting activity of TIMP-1 (7-9). The same is true for the anti-invasive and anti-metastatic activities of TIMP-1. It seems likely that a proper balance between MMPs and TIMPs is necessary for the actions of MMPs in various biological processes. All these facts suggest that the anti-MMP activity is responsible for the anti-tumor promoter activity of TIMP-1, though it cannot be excluded that TIMP-1 suppresses in vivo cell transformation by its direct action on a cell surface receptor.
It should be noted that TIMP-1 and TIMP-2 significantly suppress in vitro cell transformation at 10 and 1 ng/ml, respectively. As described above, the culture medium used in the assay system is estimated to contain~4 ng/ml (1.4ϫ10 -10 M) TIMP-1 and~1 ng/ml (0.5ϫ10 -10 M) TIMP-2. Because TIMP-1 and TIMP-2 inhibit the activity of various MMPs almost stoichiometrically (15, 45) , a small change in their concentrations might have a significant effect on MMP activities under our culture conditions. However, we could not obtain complete inhibition of cell transformation at an excess concentration of TIMP-1 or TIMP-2 (63-75% maximum inhibition). This might be explained by the possibility that proteinases which are induced by TPA but not inhibited by TIMPs, e.g. the plasminogen activator/ plasmin system, may act on the same substrates as those for MMPs.
MMPs hydrolyze various extracellular matrix proteins, including collagens, fibronectin, laminin and proteoglycan. Chen and Chen (46) reported that a serine proteinase of M r 120 000 and a metalloproteinase of M r 150 000 present in a membrane fraction were responsible for local degradation of fibronectin by Rous sarcoma virus-transformed chick embryo fibroblasts. We also reported that transformation of a rat liver epithelial cell line with the tumor virus induced expression of stromelysin 1, which appeared to be at least in part responsible for loss of the cell surface fibronectin upon transformation (13, 47) . The fact that TIMP-1 suppressed inhibition of GJIC by TPA suggests the possibility that TPA-induced MMPs may attack GJIC-related cell surface proteins, including connexins. The lowered cell-cell and cell-substrate interactions in various types of transformed cells also suggest that cell adhesion proteins such as cadherin, integrins and fibronectin may be important substrates for MMPs in the process of cell transformation.
In conclusion, the present study strongly suggests that TPA-inducible MMPs may play some role in tumor promotion and endogenous TIMPs may have a protective role against carcinogenesis.
